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ABSTRACT 
Caffeine is a commonly consumed drug during pregnancy with the potential to affect the developing 
fetus. Findings from previous studies have shown inconsistent results. We recruited a cohort of 2643 
pregnant women, aged 18-45 years, attending two UK maternity units between 8-12 weeks 
gestation from September 2003 to June 2006. We used a validated tool to assess caffeine intake at 
different stages of pregnancy and related this to late miscarriage and stillbirth, adjusting for 
confounders, including salivary cotinine as a biomarker of smoking status. There was a strong 
association between caffeine intake in the first trimester and subsequent late miscarriage and 
stillbirth, adjusting for confounders. Women whose pregnancies resulted in late miscarriage or 
stillbirth had higher caffeine intakes  (geometric mean = 145 mg/day; 95% CI: 85 to 249) than those 
with live births (103 mg/day; 95% CI: 98 to 108). Compared to those consuming <100 mg/day, odds 
ratios increased to 2.2 (95% CI: 0.7 to 7.1) for 100-199 mg/day, 1.7 (0.4 to 7.1) for 200-299 mg/day, 
and 5.1 (1.6 to 16.4) for 300+ mg/day (Ptrend=0.004). Greater caffeine intake is associated with 
increases in late miscarriage and stillbirth. Despite remaining uncertainty in the strength of 
association, our study strengthens the observational evidence base on which current guidance is 
founded. 
 
Keywords: Caffeine; miscarriage; still birth. 
 
Abbreviations:  
CI Confidence interval 
IQR  Interquartile range 
OR Odds ratio 
SD Standard deviation 
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INTRODUCTION 
Caffeine is a commonly consumed drug during pregnancy with the potential to affect the developing 
fetus.[1-3] Cohort studies have shown that maternal caffeine intake may be associated with 
decreased birth weight and fetal growth restriction,[4;5] though not consistently.[6] The only trial 
conducted suggested no substantial effect of caffeine reduction in the second half of pregnancy.[7] 
The evidence for caffeine consumption earlier in pregnancy to be a risk factor for miscarriage may 
be stronger,[8-11] but again there is still uncertainty[12-14] and no large pragmatic effectiveness 
trials have been conducted. Most guidelines recommend limiting caffeine intake immediately before 
and during pregnancy as a precaution,[15-18] whilst recognising that the strength of any association 
is still unclear.[19] 
The inconsistency in results may be attributable to one or more sources of bias, including imprecise 
estimation of caffeine intake, assuming that coffee or tea are the only sources of caffeine, 
retrospective measurement of assessment of caffeine consumption, or inadequate control for 
important confounding factors, especially smoking and alcohol consumption. To contribute to 
understanding the role of caffeine during pregnancy, using improved methodology, we examined 
the association of maternal caffeine intake with late miscarriage and intrauterine fetal death 
(stillbirth), using a highly detailed caffeine assessment tool, previously validated against both a food 
and drink diary and repeated biomarkers of caffeine intake (salivary caffeine and paraxanthine), to 
prospectively quantify total caffeine intake, from all possible sources, in the first trimester and 
throughout pregnancy.[20] We aimed to adequately correct for potentially important confounding 
from alcohol intake and most importantly from smoking using cotinine as a biomarker in a large 
cohort of pregnant women. 
 
METHODS 
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Subjects 
A cohort of 2643 pregnant women aged 18-45 years with singleton pregnancies attending two large 
UK teaching hospital maternity units was recruited between September 2003 and June 2006 
between 8-12 weeks gestation, as described in detail elsewhere.[5] Women with prior chronic 
disease, psychiatric illness, HIV or hepatitis B infection, were excluded. The demographic details of 
age, parity, maternal height, weight, socioeconomic status and gestational age were recorded by a 
questionnaire. Local ethics committee approval was obtained at both centres and written (signed) 
informed consent was obtained from each volunteer before recruitment.   
 
Outcomes and measurements 
Information regarding antenatal pregnancy complications and delivery details were obtained from 
the electronic maternity databases. The primary outcome of fetal growth restriction has been 
reported elsewhere.[5]  This paper presents our secondary outcome measure of late miscarriage 
(spontaneous pregnancy loss between 12 and 24 weeks) and stillbirth (delivery ≥24weeks with no 
signs of life at birth).   
A validated caffeine assessment tool completed during initial hospital registration at 8-12 weeks 
recorded habitual caffeine intake, divided into the four weeks before pregnancy, weeks 1-4, and 
weeks 5-12, repeated again for weeks 13-28, and again for weeks 28 to 36 weeks or end of 
pregnancy.[20] The questionnaire covered all potential dietary sources of caffeine, both food and 
drink, and over the counter medications. Specific brand names, portion sizes, methods of 
preparation, quantity and frequency of intake were collected for different gestational periods.  
Precise caffeine intakes were then estimated based on the published caffeine content for each 
item,[21] and information provided by manufacturers and coffee houses. Alcohol intake was self-
5 
 
reported using a tool developed for the UK Women’s Cohort study.[22] Self-reported smoking, 
nausea and vomiting were also collected.   
Women provided saliva samples at recruitment for determining nicotine exposure, collected using a 
Salivette® (Sarstedt, Aktiengesellschaft & Co., Loughborough, UK) kept in the mouth for 5-10 
minutes.  Saliva was isolated from the salivettes by centrifugation then stored at -80 C.  All samples 
were analysed at the University of Leeds. A commercial ELISA kit (Cozart Bioscience Ltd, Oxfordshire, 
UK) was used to measure salivary cotinine concentrations, according to the manufacturer’s 
instructions.  
 
Statistical methods 
Derived caffeine intake was expressed in mg/day averaged over the first trimester (defined as the 
first 12 weeks of pregnancy) and divided into the four weeks before pregnancy, weeks 1-4, and 
weeks 5-12 of the first trimester.  Numbers were too small to investigate associations with intake in 
the second and third trimesters.  
Geometric mean caffeine intakes were compared between those pregnancies resulting in late 
miscarriage or stillbirth and those resulting in a live birth, based on log-transformed caffeine intake 
in the first trimester.  
Unconditional logistic regression modelling was used to predict late miscarriage or stillbirth, with 
stratification for the two centres, using Stata version 10 survey facilities,[23] adjusting for mother’s 
age, previous history of miscarriage, salivary cotinine concentrations (as a continuous variable 
measured in ng/ml) and self-reported alcohol consumption, converted into units/day (one unit of 
alcohol is 10ml by volume, or 8g by weight, of pure alcohol) and categorised as 0, <0.25, 0.25 to 0.5, 
0.5 to 1, and over 1 unit/day. 
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Tests for linear trend over the continuous measure of caffeine exposure were conducted by 
inclusion of the uncategorised continuous measure in the models. The robustness of the results to 
adjustment for nausea was assessed by adding this term to the model. The robustness of the results 
to adjustment for Index of Multiple Deprivation was also assessed. In addition to adjusting for 
previous history of miscarriage, the robustness of results to excluding women with previous 
deliveries was assessed. As a further exploration of possible residual confounding by smoking, the 
models were repeated using self-reported smoking status and amount smoked added to the model. 
The models were also repeated using caffeine from each of the two main sources, tea and coffee.  
 
RESULTS 
A total of 13071 eligible women were invited to participate and 2643 (20%) consented. Women who 
had terminations were no longer at risk of miscarriage or stillbirth, and were therefore excluded 
(n=8). Of the remaining 2635 pregnancies, 19 resulted in late miscarriage and 9 in stillbirth. The 
mean (SD) maternal age was  30.0 (6.6) years. The mean pre-pregnant body mass index (SD) was 
24.5 (4.5) kg/m2. 1228 (47%) of women were primiparous, and 1324 (51%) gave birth to boys. In the 
cohort, 106 (4%) women went into pre-term labour (<37 weeks gestation) and 67 (3%) had 
gestational hypertension (systolic blood pressure over 140 mmHg, diastolic blood pressure over 90 
mmHg, on at least two occasions 30 minutes apart) or pre-eclampsia (systolic blood pressure over 
140 mmHg, diastolic blood pressure over 90 mmHg, with proteinuria).  The demographic and clinical 
characteristics are shown in table 1 according to outcome. 
[Insert Table 1 here] 
The median (IQR) caffeine intake was 217 (104 to 366) mg/day, 183 (74 to 321) mg/day, and 92 (22 
to 217) mg/day in the four weeks before pregnancy, weeks 1 to 4, and weeks 5 to 12 respectively. 
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The median (IQR) caffeine intake over the whole first trimester was 132 (58 to 241) mg/day. The 
median (IQR) caffeine intake over the whole pregnancy was 134 (63 to 232) mg/day. In our study, 
tea contributed more than half of all caffeine consumption during pregnancy.[5] The median (IQR) 
alcohol intake during the first trimester was 0.2 (0 to 0.6) units/day, with the highest consumption 
occurring, as might be expected, pre-pregnancy, and dropping rapidly in the first few weeks. 
The geometric mean caffeine intake during the first trimester for women whose pregnancies 
resulted in a live birth was 103 (95% CI: 98 to 108) mg/day. The geometric mean caffeine intake 
during the first trimester for women whose pregnancies resulted in late miscarriage or stillbirth was 
145 (85 to 249) mg/day. 
There was a strong association between caffeine intake in the first trimester and subsequent late 
miscarriage between 12 and 24 weeks or stillbirth after 24 weeks adjusting for maternal age, parity, 
alcohol intake and amount smoked measured by salivary cotinine (table 2). Compared to those 
consuming <100 mg/day, the odds ratio for late miscarriage or stillbirth increased to 2.2 (95% CI: 0.7 
to 7.1) for intakes between 100 and 199 mg/day, to 1.7 (0.4 to 7.1) for those taking between 200 
and 299 mg/day and to 5.1 (1.6 to 16.4) for those consuming over 300 mg/day (Ptrend=0.004). There 
were insufficient events to present these separately for late miscarriage and stillbirth. This 
relationship appeared strongest in relation to caffeine consumption in the first few weeks of 
pregnancy, though confidence intervals are wide.  
[Insert Table 2 here] 
The results were unchanged by further adjustment for nausea: Compared to those consuming <100 
mg/day of caffeine during the first trimester, the odds ratio for late miscarriage or stillbirth 
increased to 2.2 (95% CI: 0.7 to 7.1) for intakes between 100 and 199 mg/day, to 1.7 (0.4 to 7.1) for 
those taking between 200 and 299 mg/day and to 5.2 (1.6 to 16.6) for those consuming over 300 
mg/day (Ptrend=0.004). When adjusting for Index of Multiple Deprivation, again the results were 
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unchanged: Compared to those consuming <100 mg/day of caffeine during the first trimester, the 
odds ratio for late miscarriage or stillbirth increased to 2.2 (95% CI: 0.7 to 7.0) for intakes between 
100 and 199 mg/day, to 1.2 (0.2 to 6.0) for those taking between 200 and 299 mg/day and to 5.3 
(1.6 to 17.1) for those consuming over 300 mg/day (Ptrend=0.005). Conclusions were also unchanged 
when women with previous deliveries were excluded, though confidence intervals were wider than 
before because of the reduced numbers of cases (Ptrend=0.001). When the model was repeated using 
self-reported smoking status and amount smoked added to the model, estimates were again very 
similar: Compared to those consuming <100 mg/day of caffeine during the first trimester, the odds 
ratio for late miscarriage or stillbirth increased to 2.3 (95% CI: 0.7 to 7.4) for intakes between 100 
and 199 mg/day, to 1.7 (0.4 to 7.2) for those taking between 200 and 299 mg/day and to 5.3 (1.6 to 
17.4) for those consuming over 300 mg/day (Ptrend=0.003). 
[Insert Table 3 here] 
Tea and coffee were the dominant sources of caffeine during pregnancy. Results for these sources 
are presented in table 3 with caffeine intake categories combined to compare <200mg/day with 
200+mg/day. Wide confidence intervals reflect the small numbers of cases in the higher intake 
categories for these sources. The number of women with >200mg/day from other sources of 
caffeine was too low to investigate those sources. 
 
DISCUSSION 
Though the outcomes are rare, we have shown that there is a potentially strong association 
between caffeine and late miscarriage or stillbirth. Our results of increased late miscarriage and 
stillbirth with greater caffeine intake add further support to claims of an association between 
caffeine and negative birth outcomes.[8-12;14] Many previous studies suffered from the potential 
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for measurement error in the exposure. Our methods minimised the potential for exposure 
misclassification by including all sources of caffeine, including all caffeine-containing foods, 
beverages and medications, in a detailed validated questionnaire. Similarly, misclassification of 
important confounders can lead to bias through residual confounding. In our study, alcohol intake 
was recorded through the same detailed tool used for caffeine, and the important covariate of 
smoking status was recorded objectively using salivary cotinine as a biomarker of exposure. Many 
previous studies, particularly case-control studies, have collected exposure information 
retrospectively, with the potential for recall bias. However, in our study the exposure was assessed 
prospectively. 
Whilst our study identified only small numbers of late miscarriages and stillbirths, the proportion of 
pregnancies resulting in these outcomes (1.1%) is similar to that found in a large survey of late 
miscarriage in Canada (0.6%).[24] However the small number of events limited our power to 
investigate subgroups, and resulted in very wide confidence intervals for the estimates. Our findings 
therefore need further replication in larger prospective population-based studies. Our response rate 
(20%) was disappointing and reflects the demanding requirements of the study. For ethical reasons 
responders could not be compared to non-responders. However, mean birth weights for gestational 
age, rates of late miscarriage and stillbirth, and caffeine intakes were comparable to those found in 
other studies.[24-26] In addition, there is no reason to assume that caffeine metabolism phenotype 
should differ between responders and non-responders, other than in those confounders that we 
have adjusted for, e.g. smoking status. 
Whilst it has been suggested that the relationship between caffeine and miscarriage or stillbirth is 
confounded by nausea,[8;27] which may lead to both a reduction in caffeine intake and risk to the 
fetus, we consider that nausea is more likely to be either a marker for a healthy pregnancy, rather 
than causative, or that caffeine intake may lead to nausea in some.[8;27;28] Wherever nausea lies 
on the causal pathway, analyses both with and without adjustment for nausea gave very similar 
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results that did not alter the conclusions. In addition, we found an association with caffeine intake 
before pregnancy, which could not be influenced by physiological changes and processes during 
pregnancy (such as slowing caffeine metabolism and increasing the half life of serum caffeine). 
It may be that higher caffeine intake increases risk of late miscarriage in susceptible women. A case-
control study of women with recurrent pregnancy loss found a statistically significantly increased 
risk of pregnancy loss only in women with the homozygous (A/A) genotype representing the high 
inducibility genotype for CYP1A2, which increases the rate of caffeine metabolism.[29] Studies in 
monkeys have shown a high rate of stillbirths and miscarriage with maternal caffeine intakes of 10-
15 mg/kg body weight per day given via the drinking water, though experimental research such as 
this tends to provide evidence at doses of exposure that are not relevant to most human 
populations. For example, this is equivalent to a 60 kg woman consuming 8 to 12 average cups of 
coffee per day (assuming 75 mg caffeine/cup). Interestingly, the main serum metabolite of caffeine 
in monkeys is theophylline, whereas in humans it is paraxanthine. The comparative toxicities of 
these two metabolites is unknown.[16] Klebanoff et al., using paraxanthine as a marker for caffeine 
intake, found an increased risk of late miscarriage only for very high intakes,[13] though it is unclear 
whether it is caffeine, paraxanthine, or another caffeine metabolite that is the potentially causative 
agent. 
 
CONCLUSION 
Our study identified only small numbers of late miscarriages and stillbirths, limiting power to detect 
small associations, and resulting in very wide confidence intervals. Therefore, although reaching 
statistical significance, there is considerable uncertainty in the size of the association. However, 
given the careful methodology employed, and the advances over some earlier studies, our findings 
make a valuable contribution to the literature in this field. Given also the paucity of randomised 
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controlled trials in this area, and the practical and ethical difficulties in conducting them, our study 
strengthens the observational evidence base on which current guidance is founded. 
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Table 1. Demographic and clinical characteristics of 2635 subjects, according to outcome.  
Characteristic Late miscarriage 
or stillbirth 
(n=28) 
Live birth 
(n=2607) 
All               
(n=2635) 
Mother’s mean age (years) (SD)  30.2 (5.0) 30.0 (6.6) 30.0 (6.6) 
Mother’s mean pre-pregnant weight (kg) 
(SD) 
66.6 (13.4) 66.8 (13.1) 66.8 (13.1) 
Mother’s pre-pregnant BMI (kg/m2) (SD) 24.9 (4.3) 24.5 (4.5) 24.5 (4.5) 
History of previous miscarriage (%) 4 (14%) 611 (23%) 615 (23%) 
Gestational hypertension / pre-eclampsia 
(%) 
0 (0%) 67 (3%) 67 (3%) 
Mean alcohol intake in 1st trimester 
(units/day) (SD) 
0.5 (0.7) 0.5 (0.8) 0.5 (0.8) 
Salivary cotinine concentration (ng/ml) (%) 
     < 1 ng/ml 
     1 – 5 ng/ml 
     >5 ng/ml 
 
19 (70%) 
5 (19%) 
3 (11%) 
 
1816 (73%) 
302 (12%) 
364 (15%) 
 
1835 (73%) 
307 (12%) 
367 (15%) 
Child’s gender (male) (%) 6 (32%)* 1318 (52%) 1324 (51%) 
Mean birth weight (g) (SD) 1880 (1300) 3460 (540) 3450 (550) 
* Child’s gender not recorded for 9 late miscarriages. 
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Table 2. Odds ratios (95%CI) of late miscarriage and stillbirth by caffeine intake categories. 
 
Caffeine 
(mg/day) 
No. of 
cases / 
total 
Unadjusted 
OR 
(95% CI) Ptrend 
Adjusted 
OR* 
(95% CI) Ptrend 
Average over 
1
st
 trimester 
<100 6/998 1 - 0.04 1 - 0.004 
100-199 7/656 1.8 (0.6, 5.3)  2.2 (0.7, 7.1)  
  200-299 3/402 1.2 (0.3, 5.0)  1.7 (0.4, 7.1)  
  300+ 9/426 3.6 (1.3, 10.1)  5.1 (1.6, 16.4)  
4 weeks before 
pregnancy 
<100 3/604 1 - 0.002 1 - <0.001 
100-199 5/570 1.8 (0.4, 7.5)  1.4 (0.3, 6.3)  
200-299   5/460 2.2 (0.5, 9.3)  2.2 (0.5, 9.4)  
  300+ 12/870 2.8 (0.8, 10.0)  3.0 (0.8, 10.9)  
Weeks 1 to 4 <100 3/781 1 - 0.001 1 - <0.001 
 100-199 5/572 2.3 (0.5, 9.6)  1.8 (0.4, 8.2)  
  200-299   6/441 3.6 (0.9, 14.4)  3.8 (0.9, 16.7)  
  300+ 11/706 4.1 (1.1, 14.8)  4.7 (1.2, 18.7)  
Weeks 5 to 12 <100 12/1302 1 - 0.6 1 - 0.2 
 100-199 3/497 0.7 (0.2, 2.3)  0.8 (0.2, 3.0)  
  200-299   6/325 2.0 (0.8, 5.4)  2.5 (0.9, 7.0)  
  300+ 4/373 1.2 (0.4, 3.6)  1.6 (0.5, 5.5)  
*Adjusted odds ratios take account of maternal age, parity, amount smoked (cotinine concentration 
as a continuous variable, ng/ml) and alcohol intake (categorised as 0, <0.25, 0.25-0.5, 0.5-1 and 1+ 
units/day). Where numbers do not total to 2635, this is due to a small proportion of missing data. A 
total of 271 women were excluded from adjusted analyses with missing covariate information. 
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Table 3. Odds ratios (95%CI) of late miscarriage and stillbirth by tea and coffee intake categories. 
 
Caffeine 
(mg/day) 
No. of 
cases / 
total 
Unadjusted 
OR 
(95% CI) Ptrend 
Adjusted 
OR* 
(95% CI) Ptrend 
Tea <200 17/2021 1 - 0.07 1 - 0.02 
  200+ 8/500 1.9 (0.8, 4.5)  2.2 (0.9, 5.4)  
Coffee <200 24/2414 1 - 0.4 1 - 0.3 
  200+ 1/107 0.9 (0.1, 7.0)  1.2 (0.1, 9.4)  
*Adjusted odds ratios take account of maternal age, parity, amount smoked (cotinine concentration 
as a continuous variable, ng/ml) and alcohol intake (categorised as 0, <0.25, 0.25-0.5, 0.5-1 and 1+ 
units/day). Where numbers do not total to 2635, this is due to a small proportion of missing data. A 
total of 271 women were excluded from adjusted analyses with missing covariate information. 
 
